|
№
|
Name of the service
|
Unit
|
Price KZT
|
| Allergy diagnostics |
| CDL -
Allergens domestic/molecular (А) |
| 69 |
СDL -
Domestic/molecular allergens (A) |
1 test |
6 800 |
| 70 |
СDL - Fungal
allergens (D) |
1 test |
6 800 |
| 71 |
СDL - Tree allergens
(T) |
1 test |
6 800 |
| 72 |
СDL - Domestic dust
allergens (H) |
1 test |
6 800 |
| 73 |
СDL - Animal
allergens (E) |
1 test |
6 800 |
| 74 |
СDL - Inhalant
allergens (IP) |
1 test |
6 800 |
| 75 |
СDL - Drug allergens
© |
1 test |
6 800 |
| 76 |
СDL - Insect
allergens (I) |
1 test |
6 800 |
| 77 |
СDL - Parasitic
allergens (P) |
1 test |
6 800 |
| 78 |
СDL - Food-based
allergens (F) |
1 test |
6 800 |
| 79 |
СDL - Musty allergens
(M) |
1 test |
6 800 |
| 80 |
СDL - Professional
allergens (K) |
1 test |
6 800 |
| 81 |
СDL - Other allergens
(O) |
1 test |
6 800 |
| 82 |
СDL - Weed allergens
(W) |
1 test |
6 800 |
| 83 |
СDL - Allergens of
grasses and grains (G) |
1 test |
6 800 |
| Biochemical screens |
| Biochemical blood tests. Protein metabolism |
| 84 |
Albumen |
1 test |
1 900 |
| 85 |
Bence
Jones protein in urine |
1 test |
58 157 |
| 86 |
Protein
immunotyping (M-gradient) |
1 test |
51 000 |
| 87 |
Creatinine |
1 test |
1 500 |
| 88 |
Uric
acid |
1 test |
1 800 |
| 89 |
Urea |
1 test |
1 700 |
| 90 |
Total
protein |
1 test |
1 700 |
| 91 |
Blood
protein electrophoresis (Protein fractions) |
1 test |
5 600 |
| Biochemical blood tests. Iron metabolism |
| 92 |
Transferrin |
1 test |
4 200 |
| 93 |
Ferritin |
1 test |
5 900 |
| 94 |
Total
Iron-Binding Capacity (TIBS) |
1 test |
5 440 |
| Biochemical blood tests. Lipoprotein metabolism |
| 95 |
Apolipoprotein
A (Apo-A) |
1 test |
3 200 |
| 96 |
Apolipoprotein
B (Apo-B) |
1 test |
3 200 |
| 97 |
High
density lipoproteins (HDL) |
1 test |
3 400 |
| 98 |
Low-density
lipoproteins (LDL) |
1 test |
3 000 |
| 99 |
Triglycerides
(TG) |
1 test |
1 700 |
| 100 |
Cholesterol
(CS) |
1 test |
2 100 |
| Biochemical blood tests. Pigment metabolism |
| 101 |
Total
bilirubin |
1 test |
1 800 |
| 102 |
Conjugated
bilirubin |
1 test |
1 800 |
| Biochemical blood tests. Carbohydrate metabolism |
| 103 |
Glycosylated
hemoglobin (Hemoglobin A1c, HbA1c) |
1 test |
4 900 |
| 104 |
Glucose |
1 test |
1 500 |
| 105 |
Glucose
on the glucometer |
1 test |
600 |
| Biochemical blood tests. Enzymes |
| 106 |
Alanine
aminotransferase (ALT) |
1 test |
1 700 |
| 107 |
Alpha
amylase |
1 test |
3 200 |
| 108 |
Pancreatic
amylase |
1 test |
5 600 |
| 109 |
Aspartate
aminotransferase (AST) |
1 test |
3 000 |
| 110 |
Gamma
glutamyl transferase (GGTP) |
1 test |
4 000 |
| 111 |
Creatinine
kinase-MB fraction (CFK-MB) |
1 test |
2 900 |
| 112 |
Creatine
phosphokinase (CPK) |
1 test |
3 000 |
| 113 |
Lactate
dehydrogenase (LDH) |
1 test |
3 400 |
| 114 |
Alkaline
phosphatase (ALP) |
1 test |
2 200 |
| 115 |
Lipase |
1 test |
4 250 |
| Biochemical urine tests |
| 116 |
Glucose
in a single urine portion |
1 test |
2 200 |
| 117 |
Glucose
in daily urine |
1 test |
2 400 |
| 118 |
Urine
Ca++ |
1 test |
2 300 |
| 119 |
Urine
creatinine |
1 test |
2 000 |
| 120 |
Urine
Mg++ |
1 test |
2 000 |
| 121 |
Urine
uric acid |
1 test |
2 000 |
| 122 |
Urine
urea |
1 test |
2 200 |
| 123 |
Microalbumin
complex (Creatinine/albumin ratio) |
1 test |
14 100 |
| 124 |
Relative
indices of metabolic disorders (ratio calcium/creatinine,
magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine |
1 test |
6 900 |
| 125 |
Relative
index of metabolic disorders (calcium/creatinine ratio) |
1 test |
4 900 |
| 126 |
Relative
index of metabolic disorders (magnesium/creatinine ratio) |
1 test |
5 200 |
| 127 |
Relative
index of metabolic disorders (inorganic uric acid/creatinine ratio) |
1 test |
4 500 |
| 128 |
Relative
index of metabolic disorders (inorganic phosphorus/creatinine ratio) |
1 test |
4 400 |
| 129 |
Rehberg
test |
1 test |
5 100 |
| 130 |
Glomerular
filtration rate |
1 test |
4 000 |
| 131 |
Urine
osmolarity |
1 test |
1 000 |
| 132 |
Urine
phosphorus |
1 test |
1 700 |
| 133 |
Urine
potassium |
1 test |
1 700 |
| 134 |
Sodium
urine |
1 test |
1 700 |
| 135 |
Chlorine
urine |
1 test |
1 700 |
| Biochemistry |
| 136 |
Blood
osmolarity |
1 test |
2 500 |
| Immune status |
| 137 |
Immunoglobulin
A |
1 test |
4 000 |
| 138 |
Immunoglobulin
G |
1 test |
4 000 |
| 139 |
Immunoglobulin
M |
1 test |
4 000 |
| 140 |
Complement
C3 |
1 test |
5 270 |
| 141 |
Complement
C4 |
1 test |
4 900 |
| Hemostatic system testings |
| 142 |
Thrombocyte
aggregation with P2Y (PFA 200 analyzer) |
1 test |
39 600 |
| 143 |
Thrombocyte
aggregation with ADF (PFA 200 analyzer) |
1 test |
39 600 |
| 144 |
Thrombocyte
aggregation with Epinephrine (PFA 200 analyzer) |
1 test |
37 400 |
| 145 |
Activated
partial/batch thromboplastin time (APTT/ABTT) |
1 test |
2 500 |
| 146 |
Antithrombin
III (AT-3) |
1 test |
5 200 |
| 147 |
Lupus
anticoagulant (Lupus test) |
1 test |
7 600 |
| 148 |
Duke
bleeding time |
1 test |
1 700 |
| 149 |
Clotting
time according to Sukharev |
1 test |
1 700 |
| 150 |
D-Dimer
Exclusion quantification |
1 test |
13 900 |
| 151 |
D-dimer
(by turbidimetric immunoassay), quantification |
1 test |
17 000 |
| 152 |
Coagulogram
- complex No. 1 (APTT, INR, PT, PTI, fibrinogen, TT) |
1 test |
6 800 |
| 153 |
Coagulogram
- complex No. 2 (APTT, INR, PT, PTI, fibrinogen, TT+ SFMC) |
1 test |
9 300 |
| 154 |
International
normalized ratio (INR) |
1 test |
1 800 |
| 155 |
Protein
С |
1 test |
5 400 |
| 156 |
Prothrombin
time (PT) |
1 test |
1 700 |
| 157 |
Prothrombin
index (PTI) |
1 test |
1 700 |
| 158 |
Soluble
fibrin-monomer complexes (SFMC) |
1 test |
2 500 |
| 159 |
C1
inhibitor |
1 test |
20 400 |
| 160 |
Thrombin
time (TT) |
1 test |
1 800 |
| 161 |
Thromboelastogram
with heparinase |
1 test |
19 800 |
| 162 |
Thromboelastogram
with kaolin |
1 test |
15 300 |
| 163 |
Fibrinogen |
1 test |
2 500 |
| 164 |
INR/PT/Quick
value in capillary blood |
1 test |
13 600 |
| Specific proteins |
| 165 |
Alpha
- 1 - antitrypsin |
1 test |
8 100 |
| 166 |
Antistreptolysin
O (ASL-O) quantitation |
1 test |
4 700 |
| 167 |
Haptoglobin |
1 test |
2 700 |
| 168 |
Myoglobin
quantification |
1 test |
3 600 |
| 169 |
Rheumatoid
factor (RF), quantification |
1 test |
3 900 |
| 170 |
C-reactive
protein (CRP) quantitation |
1 test |
4 000 |
| 171 |
Ceruloplasmin |
1 test |
6 900 |
| Electrolytes, mineral metabolism |
| 172 |
Antibodies
to TSH receptors (anti-TSHr, TSH receptor antibodies, a-rTSH) |
1 test |
14 600 |
| 173 |
Ionized
calcium |
1 test |
5 600 |
| 174 |
Serum
iron (Fe) |
1 test |
3 000 |
| 175 |
Potassium |
1 test |
1 700 |
| 176 |
Total
calcium (Ca) |
1 test |
2 000 |
| 177 |
Acid-base
state (ABS) of blood (Blood gases) |
1 test |
9 100 |
| 178 |
Magnesium
(Mg) |
1 test |
2 700 |
| 179 |
Copper
(Cu) |
1 test |
2 100 |
| 180 |
Sodium |
1 test |
1 700 |
| 181 |
Organic
phosphorus (P) |
1 test |
2 800 |
| 182 |
Chlorine |
1 test |
1 700 |
| 183 |
Electrolytes
(potassium, sodium, ionized calcium, chlorine) in blood serum |
1 test |
7 600 |
| 184 |
Acid-base
state of blood, on a portable analyzer of gases, electrolytes and blood
metabolites |
1 test |
17 000 |
| Hematological tests |
| 185 |
LE-phenomenon
(LE - cells, lupus cells) |
1 test |
5 100 |
| 186 |
Blood
test for malarial plasmodium using the “thin smear” and “thick smear” method |
1 test |
2 100 |
| 187 |
CBC+DIFF |
1 test |
3 700 |
| 188 |
CBC
(short) (without WBC) |
1 test |
2 000 |
| 189 |
Reticulocyte
count |
1 test |
2 000 |
| 190 |
Thrombocyte
count according to Fonio |
1 test |
2 000 |
| Immune status |
| 191 |
Indicators
of cellular immunity (L/cytes; T-l/cytes-CD3+; T-helper cells-CD3.4+;
T-cytotoxic - CD3.8+; B-l/cytes CD3-.19+; Natural killer cells - CD3
-,16,56+) |
1 test |
32 300 |
| 192 |
Phagocytosis
(oxygen-independent) |
1 test |
17 800 |
| Immunology research |
| Vitamins |
| 193 |
Vitamin
D total, 25-OH-VitD |
1 test |
11 407 |
| 194 |
Vitamin
D3, 25-OH-VitD3 |
1 test |
11 500 |
| 195 |
Vitamin
B12, Cyanocobalamin |
1 test |
5 100 |
| 196 |
Active
Vitamin B12, Holotranscobalamin |
1 test |
10 800 |
| 197 |
Folic
acid (Folate) |
1 test |
5 200 |
| Gastropanel BIOHIT |
| 198 |
Immunological
characteristics of the gastric mucosa (Gastropanel: pepsinogen I, pepsinogen
II, gastrin-17B, gastrin-17S, Anti-Heli |
1 test |
39 100 |
| Hormones of the pituitary-adrenal system in the blood |
| 199 |
Adrenocorticotropic
hormone (ACTH) |
1 test |
7 100 |
| 200 |
Aldosterone |
1 test |
7 100 |
| 201 |
Growth
hormone (Somatotropic hormone, hGH) |
1 test |
8 500 |
| 202 |
Dehydroepiandrosterone
sulfate (DHEA-s) |
1 test |
8 500 |
| 203 |
Cortisol |
1 test |
6 800 |
| 204 |
Catecholamines
(adrenaline, noradrenaline, dopamine) in blood plasma by ELISA |
1 test |
39 100 |
| 205 |
Melatonin
in blood serum by ELISA method, quantitative determination |
1 test |
24 600 |
| Hormones of the pituitary-adrenal system in the urine |
| 206 |
Adrenaline
(epinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
24 600 |
| 207 |
Dopamine
in blood serum by ELISA method, quantitative determination |
1 test |
24 600 |
| 208 |
Noradrenaline
(norepinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
24 600 |
| 209 |
Vanillyl
mandelic acid in daily urine (VMA, 24h urine) |
1 test |
9 300 |
| 210 |
Homovanillic
acid in daily urine (HVA, 24h urine) |
1 test |
9 300 |
| 211 |
Cortisol
in daily urine (Cortisol, 24h urine) |
|
8 300 |
| Pancreatic hormones |
| 212 |
Insulin |
1 test |
5 200 |
| 213 |
Binding
peptide (C-Peptide) |
1 test |
5 900 |
| Reproductive system hormones |
| 214 |
Anti-Mullerian
hormone, AMH, MIS |
1 test |
12 700 |
| 215 |
Sex
hormone binding globulin (SHBG) |
1 test |
8 100 |
| 216 |
Luteinizing
hormone (LH) |
1 test |
3 700 |
| 217 |
Progesterone |
1 test |
4 200 |
| 218 |
Prolactin |
1 test |
3 900 |
| 219 |
Testosterone |
1 test |
5 400 |
| 220 |
Follicle
stimulating hormone (FSH) |
1 test |
3 700 |
| 221 |
Estradiol |
1 test |
4 500 |
| Thyroid hormones |
| 222 |
Antibodies
to thyroglobulin (Anti-Tg) |
1 test |
5 900 |
| 223 |
Antibodies
to thyroid peroxidase (Anti-TPO) |
1 test |
4 900 |
| 224 |
Thyroglobulin
(Tg) |
1 test |
5 900 |
| 225 |
Thyroid
stimulating hormone (TSH) |
1 test |
4 200 |
| 226 |
Total
thyroxine (total T4) |
1 test |
5 100 |
| 227 |
Free
thyroxine (FT4) |
1 test |
4 400 |
| 228 |
Total
triiodothyronine (total T3) |
1 test |
4 500 |
| 229 |
Free
triiodothyronine (FT3) |
1 test |
4 500 |
| Autoimmune pathology diagnostics (EIA, ECLIA) |
| 230 |
Antimitochondrial
antibodies M2 subtype (AMA-M2) |
1 test |
11 500 |
| 231 |
Antineutrophil
cytoplasmic antibodies screening (ANCA-screen) |
1 test |
12 750 |
| 232 |
Antinuclear
antibodies screening (ANA screen) |
1 test |
11 500 |
| 233 |
Antinuclear
antibodies screening (ANA-Detect) |
1 test |
11 500 |
| 234 |
Antibodies
to GBM in blood serum by ELISA method |
1 test |
14 100 |
| 235 |
Antibodies
to beta-2-glycoprotein I (Anti-ß-2 Glycoprotein) |
1 test |
11 300 |
| 236 |
Antibodies
to double-stranded DNA (a-dsDNA) |
1 test |
11 500 |
| 237 |
Antibodies
to single-stranded DNA (a-ssDNA) |
1 test |
11 500 |
| 238 |
Antibodies
to gastric parietal cells (a-Parietal cell IgG) |
1 test |
11 500 |
| 239 |
Antibodies
to tissue transglutaminase screening (a-tTG IgA,G) |
1 test |
11 500 |
| 240 |
Antibodies
to elastase (Anti-Elastase) |
1 test |
11 500 |
| 241 |
Class
A antibodies to Saccharomyces cerevisiae (ASCA IgA) |
1 test |
11 500 |
| 242 |
Class
G antibodies to Saccharomyces cerevisiae (ASCA IgG) |
1 test |
11 500 |
| 243 |
Class
G antibodies to histones (a-Histone IgG) |
1 test |
12 700 |
| 244 |
Class
G antibodies to cardiolipin (A-Cardiolipin IgG) |
1 test |
12 700 |
| 245 |
Class
G antibodies to modified citrullinated vimentin (A-MCV IgG) |
1 test |
13 900 |
| 246 |
Class
G antiphospholipid antibodies (AFL IgG) |
1 test |
12 500 |
| 247 |
Class
M antibodies to cardiolipin (A-Cardiolipin IgM) |
1 test |
12 500 |
| 248 |
Class
M antiphospholipid antibodies (AFL IgM) |
1 test |
11 500 |
| 249 |
Anti-Prothrombin
screening |
1 test |
11 500 |
| 250 |
Antibodies
to insulin (A-insulin) |
1 test |
12 700 |
| 251 |
Total
antibodies class A, M, G to cardiolipin, screening (A-Cardiolipin total) |
1 test |
11 500 |
| 252 |
Extractable
nuclear antibodies, extensive assay (ENA combi) |
1 test |
37 000 |
| 253 |
Antineutrophil
cytoplasmic antibodies, extensive assay (ANCA-combi) |
1 test |
57 400 |
| 254 |
Antinuclear
antibodies, extensive analysis (ANA combi) |
1 test |
41 600 |
| 255 |
Antisperm
antibodies (ASA) |
1 test |
18 700 |
| 256 |
IgG
antibodies to cyclic citrullinated peptide (a-CCP) |
1 test |
25 800 |
| 257 |
Antibodies
to insulin in blood serum by ELISA method, quantitation |
1 test |
8 500 |
| 258 |
Extractable
nuclear antibodies, screening (ENA screen) |
1 test |
11 000 |
| 259 |
"ANA
pro" for semi-quantitative determination of IgG antibodies to nuclear
and cytoplasmic antigens in human serum and plasma |
1 test |
34 000 |
| 260 |
"ANCA
Dot" for the qualitative determination of IgG antibodies to
myeloperoxidase (MPO), proteinase 3 (PR-3) and glomerular basement membrane
(GBM) in human serum and plasma |
1 test |
39 100 |
| 261 |
"ANA 12 LINE" for the qualitative
determination of IgG antibodies to nuclear and cytoplasmic antigens in human
serum and plasma |
1 test |
42 500 |
| Autoimmune pathology diagnostics (LIA tests) |
| 262 |
Antibodies
in autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM) |
1 test |
44 500 |
| 263 |
Antibodies
in autoimmune liver diseases IMTEC-Liver-LIA S (IgG to AMA M2, Sp100, LKM1,
gp210, LC1 and SLA) |
1 test |
22 900 |
| 264 |
Antinuclear
antibodies ANA-LIA (IgG to nucleosomes, dsDNA, histones, SmD1, U1-snRNP,
SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0) |
1 test |
10 500 |
| 265 |
Antinuclear
antibodies ANA-LIA MAXX: IgG to nucleosomes, dsDNA, histones, SmD1, PCNA, P0,
SS-A/Ro60 and 52kD, SS–B/La, CENP-B, Scl-70, U1-snRNP, AMA M2, Jo-1, PM-Scl,
Mi-2(β), Ku |
1 test |
46 900 |
| 266 |
Antibodies
in autoimmune myositis IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP
and Ku) |
1 test |
23 900 |
| 267 |
Antibodies
for celiac disease IMTEC-Celiac Disease-LIA S (IgA and IgG to gliadin, tissue
transglutaminase) |
1 test |
10 200 |
| 268 |
Antibodies
in gastrointestinal diseases Gastro-LIA (IgA and IgG to gliadin, tTG, mannan,
PCA, Castle factor) |
1 test |
31 900 |
| Autoimmune pathology diagnostics using indirect
immunofluorescence (inDIF) |
| 269 |
Antikeratin
antibodies (AKA) by indirect immunofluorescence (inDIF) |
1 test |
14 025 |
| 270 |
Antineutrophil
cytoplasmic antibodies (ANCA) by indirect immunofluorescence (inDIF) |
1 test |
10 285 |
| 271 |
Antinuclear
factor on the HEp-2 cell line (ANF) by indirect immunofluorescence (inDIF) |
1 test |
14 025 |
| 272 |
Antibodies
to native DNA (a-nDNA) by indirect immunofluorescence (inDIF) |
1 test |
14 025 |
| 273 |
Autoantibodies
by the method (nRIF) on a triple substrate (LKM-1, Antibodies to gastric
parietal cells, to smooth muscles (F-actin), ANF on the HEp-2 cell line,
AMA-M1.9) |
1 test |
14 025 |
| Immune status |
| 274 |
Alpha
interferon in the blood |
1 test |
13 600 |
| 275 |
Gamma
interferon in the blood |
1 test |
13 600 |
| 276 |
Secretory
immunoglobulin A in blood serum (sIgA) |
1 test |
8 100 |
| 277 |
Total
Immunoglobulin E (total IgE) |
1 test |
9 000 |
| 278 |
Immunophenotyping
of HLA B27 in blood using flow cytometry |
1 test |
34 000 |
| 279 |
Interleukin-10 |
1 test |
11 000 |
| 280 |
Interleukin-2 |
1 test |
13 600 |
| 281 |
Interleukin-6 |
1 test |
13 600 |
| 282 |
Interleukin-8 |
1 test |
11 000 |
| 283 |
Interleukin
- 13 (IL-13) in serum and blood plasma |
1 test |
29 700 |
| 284 |
Interleukin
- 3 (IL-3) in serum and blood plasma |
1 test |
52 700 |
| 285 |
Interleukin
- 5 (IL-5) in serum and blood plasma |
1 test |
29 700 |
| 286 |
Interleukin
- 1 beta (IL-1-beta, IL-1-β) in human biological fluids and culture media by
ELISA method, quantitation |
1 test |
14 900 |
| 287 |
Interleukin
- 13 (IL-13, IL-13) in blood serum by ELISA method, quantitation |
1 test |
16 100 |
| 288 |
Interleukin
- 18 (IL-18, IL-18) in blood serum by ELISA method, quantitation |
1 test |
12 900 |
| 289 |
Interleukin
- 3 (IL-3, IL-3) in blood serum by ELISA method, quantitation |
1 test |
16 100 |
| 290 |
Interleukin
- 4 (IL-4, IL-4) in blood serum by ELISA method, quantitation |
1 test |
13 200 |
| 291 |
Interleukin
- 5 (IL-5, IL-5) in blood serum by ELISA method, quantitation |
1 test |
16 100 |
| 292 |
Eosinophil
cationic protein (ECP) |
1 test |
10 300 |
| 293 |
Tryptase |
1 test |
13 200 |
| Serological markers of
coronavirus infection SARS-CoV-2 (COVID-19, 2019-nCoV) |
| 294 |
IgM
antibodies to SARS-CoV-2 (qualitative) |
1 test |
7 300 |
| 295 |
IgG
antibodies to SARS-CoV-2 (qualitative) |
1 test |
7 300 |
| 296 |
nCoV
antibodies - Nab (post-vaccination, quantitative) |
1 test |
8 500 |
| 297 |
Immunoglobulin
G to SARS-CoV-2 (quantitative) |
1 test |
8 500 |
| 298 |
Immunoglobulin
M to SARS-CoV-2 (quantitative) |
1 test |
10 200 |
| 299 |
IgG/IgM
antibodies to SARS-CoV-2 (Rapid test) (qualitative) |
1 test |
11 000 |
| 300 |
Sars-CoV-2
specific antigen (rapid test) (qualitative) |
1 test |
9 100 |
| Drug monitoring |
| 301 |
Tacrolimus
in blood serum by immunochemiluminescence |
1 test |
16 300 |
| Markers of sepsis |
| 302 |
Procalcitonin,
PCT (quantitation by enzyme immunoassay) |
1 test |
14 900 |
| 303 |
Procalcitonin,
PCT (quantitation by immunofluorescence method) |
1 test |
14 700 |
| Bone metabolism |
| 304 |
Osteocalcin
(N-MID Osteocalcin) |
1 test |
6 800 |
| 305 |
Parathyroid
hormone (PTH) |
1 test |
6 800 |
| 306 |
Pyrilinks-D
(DPD) |
1 test |
6 100 |
| Tumor markers |
| 307 |
Alpha
1-fetoprotein (AFP) |
1 test |
6 100 |
| 308 |
Squamous
cell carcinoma antigen (SCC-Ag) |
1 test |
6 600 |
| 309 |
Calcitonin |
1 test |
8 500 |
| 310 |
Neuron
- specific enolase (NSE, NSE) in blood serum by immunochemiluminescence |
1 test |
9 000 |
| 311 |
Progastrin
releasing peptide (ProGRP) |
1 test |
9 000 |
| 312 |
Prostate-specific
antigen total (PSA total, PSA total) |
1 test |
4 900 |
| 313 |
Prostate-specific
antigen free (PSA free) |
1 test |
4 500 |
| 314 |
Carcinoembryonic
antigen (CEA, CEA) |
1 test |
5 700 |
| 315 |
Cancer
antigen 72-4 (CA 72-4) |
1 test |
11 000 |
| 316 |
Cancer
antigen 125 (CA 125) |
1 test |
7 100 |
| 317 |
Cancer
antigen 15-3 (CA 15-3) |
1 test |
6 600 |
| 318 |
Cancer
antigen 19-9 (CA 19-9) |
1 test |
6 900 |
| 319 |
Cancer
antigen 242 (CA 242) |
1 test |
13 900 |
| 320 |
Tumor
necrosis factor-alpha (TNF-α, α-TNF) |
1 test |
9 300 |
| 321 |
Cytokeratin
fragment 19 (Cyfra21-1) |
1 test |
9 300 |
| 322 |
Human
chorionic gonadotropin intact + beta subunit (HCG+beta) |
1 test |
9 300 |
| 323 |
Total
human chorionic gonadotropin in urine (HCG urine) |
1 test |
7 600 |
| 324 |
Total
human chorionic gonadotropin (HCG) |
1 test |
3 900 |
| 325 |
Human
epididymal protein 4 (HE4) |
1 test |
11 000 |
| Other tests |
| 326 |
Homocysteine
(Hcy-SH) |
1 test |
11 000 |
| 327 |
Erythropoietin
(EPO) |
1 test |
7 300 |
| 328 |
Pancreatic
elastase content in feces |
1 test |
25 500 |
| Serological markers of brucellosis |
| 329 |
Class
A antibodies to the causative agent of brucellosis |
1 test |
6 800 |
| 330 |
Class
G antibodies to the causative agent of brucellosis |
1 test |
6 800 |
| 331 |
Class
M antibodies to the causative agent of brucellosis |
1 test |
6 800 |
| Serological markers of viral hepatitis D |
| 332 |
Total
class M, G antibodies to hepatitis D virus (a-HDV total) |
1 test |
5 100 |
| Serological markers of viral hepatitis A |
| 333 |
Class
M antibodies to hepatitis A virus (a-HAV IgM) |
1 test |
4 000 |
| Serological markers of viral hepatitis B |
| 334 |
Hepatitis
B virus "e" antigen (HBeAg) |
1 test |
4 300 |
| 335 |
Class
G antibodies to the “e” antigen of the hepatitis B virus (a-HBeAg IgG) |
1 test |
3 900 |
| 336 |
Antibodies
class G to the nuclear antigen of the hepatitis B virus (a-HBcAg IgG) |
1 test |
4 500 |
| 337 |
Antibodies
class M to the nuclear antigen of the hepatitis B virus (a-HBcAg IgM) |
1 test |
4 400 |
| 338 |
Hepatitis
B surface antigen (HBsAg, Australian antigen) |
1 test |
4 000 |
| 339 |
Total
antibodies class M, G to the “e” antigen of the hepatitis B virus (a-HBeAg
total) |
1 test |
4 400 |
| 340 |
Total
antibodies class M, G to the surface antigen of the hepatitis B virus
(a-HBsAg total) |
1 test |
4 900 |
| 341 |
Total
antibodies class M, G to the nuclear antigen of the hepatitis B virus
(a-HBcAg total) |
1 test |
5 400 |
| 342 |
НBsAg,
Rapid test (Hepatitis B surface antigen, qualitation) |
1 test |
3 000 |
| Serological markers of viral hepatitis C |
| 343 |
Hepatitis
C virus antigen (HCV Ag) |
1 test |
14 400 |
| 344 |
Antibodies
class M to hepatitis C virus (HCV IgM) |
1 test |
5 900 |
| 345 |
Total
antibodies class M, G to hepatitis C virus (a-HCV total) |
1 test |
4 800 |
| 346 |
a-HCV,
Rapid test (Specific antibodies to hepatitis C virus, qualitation) |
1 test |
3 200 |
| Serological markers of HIV infection |
| 347 |
HIV
p24 antigen and antibodies to human immunodeficiency virus types 1, 2
(HIV-1/2, HIV-1/2) |
1 test |
5 100 |
| 348 |
Immunochromatic
rapid test of the third generation for the determination of antibodies to
human immunodeficiency virus types 1 and 2 (a-HIV-1/2) |
1 test |
3 400 |
| 349 |
Express
test for determining the free antigen HIV-1 p24 antibodies and antibodies to
human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) |
1 test |
5 400 |
| 350 |
ELISA
for the presence of antibodies to the human immunodeficiency virus (HIV, AIDS
center) |
1 test |
4 200 |
| Serological markers of herpes infection |
| 351 |
Class
G antibodies to herpes simplex virus type 8 (HSV-8-IgG) |
1 test |
4 500 |
| 352 |
Class
G antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgG) |
1 test |
5 100 |
| 353 |
Class
G antibodies to herpes simplex virus type 1 (HSV-1-IgG) |
1 test |
3 600 |
| 354 |
Class
G antibodies to herpes simplex virus type 2 (HSV-2-IgG) |
1 test |
4 700 |
| 355 |
Antibodies
class G to herpes simplex virus type 6, (HHV-6-IgG) |
1 test |
5 100 |
| 356 |
Class
M antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgM) |
1 test |
4 700 |
| 357 |
Class
M antibodies to herpes simplex virus type 2 (HSV-2-IgM) |
1 test |
5 600 |
| 358 |
Antibodies
class M to herpes simplex virus type 1 (HSV-1-IgM) |
1 test |
4 200 |
| 359 |
Avidity
index of class G antibodies to herpes simplex virus types 1 and 2
(HSV–1,2-IgG–Avidity) |
1 test |
5 200 |
| 360 |
Avidity
index of class G antibodies to herpes simplex virus type 2
(HSV–2-IgG–Avidity) |
1 test |
5 200 |
| Serological markers of infectious mononucleosis |
| 361 |
Class
G antibodies to Epstein-Barr virus early antigen (EBV-EA IgG) |
1 test |
5 400 |
| 362 |
Class
G antibodies to Epstein-Barr virus nuclear antigen (EBV-NA IgG) |
1 test |
5 400 |
| 363 |
Class
G antibodies to Epstein-Barr virus capsid antigen (EBV-VCA IgG) |
1 test |
5 400 |
| 364 |
Antibodies
class M to Epstein-Barr virus capsid antigen (EBV-VCA IgM) |
1 test |
5 400 |
| 365 |
Index
of avidity of class G antibodies to the capsid antigen of the Epstein-Barr
virus (EBV-VCA IgG-Avidity) |
1 test |
5 900 |
| Serological markers of rubella |
| 366 |
Class
G antibodies to rubella virus (Rubella IgG) |
1 test |
4 400 |
| 367 |
Class
M antibodies to rubella virus (Rubella IgM) |
1 test |
4 700 |
| 368 |
Avidity
index of class G antibodies to rubella virus (Rubella IgG-Avidity) |
1 test |
5 400 |
| Serological markers of listeriosis |
| 369 |
Class
G antibodies to Listeria monocytogenes |
1 test |
3 700 |
| Serological markers of cytomegalovirus infection |
| 370 |
Antibodies
of class G and M to the immediate early protein of cytomegalovirus
(CMV-IEA-IgG/M) |
1 test |
6 100 |
| 371 |
Antibodies
class G to cytomegalovirus (CMV IgG) |
1 test |
6 200 |
| 372 |
Antibodies
class M to cytomegalovirus (CMV IgM) |
1 test |
6 100 |
| 373 |
Index
of avidity of class G antibodies to cytomegalovirus (CMV-IgG-Avidity) |
1 test |
5 900 |
| Serological markers. Antibodies to protozoa, parasites and
fungi |
| 374 |
Class
G antibodies to fungi of the genus Candida albicans (Candida albicans IgG) |
1 test |
5 900 |
| 375 |
Class
A antibodies to Trichomonas (Trichomonas vaginalis IgA) |
1 test |
5 900 |
| 376 |
Class
G antibodies to Ascaris antigens
(Ascaris lumbricoides IgG) |
1 test |
5 900 |
| 377 |
Class
G antibodies to Aspergillus antigens (Aspergillus IgG) |
1 test |
5 900 |
| 378 |
Class
G antibodies to Opisthorchis antigens (a-Opistorhide IgG) |
1 test |
5 900 |
| 379 |
Class
G antibodies to Toxocara antigens (a-Toxocara IgG) |
1 test |
5 900 |
| 380 |
Class
G antibodies to Trichinella antigens (a-Trichinella IgG) |
1 test |
5 900 |
| 381 |
Class
G antibodies to Echinococcus unilocular antigens (a-Echinococcus IgG) |
1 test |
5 900 |
| 382 |
Class
G antibodies to Toxoplasma (Toxoplasma gondii IgG) |
1 test |
5 900 |
| 383 |
Class
G antibodies to Trichomonas (Trichomonas vaginalis IgG) |
1 test |
5 900 |
| 384 |
Class
A antibodies to Toxoplasma (Toxoplasma gondii IgA) |
1 test |
5 900 |
| 385 |
Class
M antibodies to Toxoplasma (Toxoplasma gondii IgM) |
1 test |
5 900 |
| 386 |
Avidity
index of class G antibodies to Toxoplasma (Toxoplasma gondii IgG–Avidity) |
1 test |
4 900 |
| 387 |
Specific
circulating immunocomplexes (CICs) containing opisthorchis antigens |
1 test |
6 400 |
| 388 |
Total
antibodies of class A, M, G to lamblia (a-Lamblia total) |
1 test |
5 100 |
| Serological markers. Bacterial antibodies |
| 389 |
Class
A antibodies to mycoplasma (Mycoplasma hominis IgA) |
1 test |
5 100 |
| 390 |
Class
A antibodies to ureaplasma (Ureaplasma urealyticum IgA) |
1 test |
5 100 |
| 391 |
Class
G antibodies to ureaplasma (Ureaplasma urealyticum IgG) |
1 test |
5 100 |
| 392 |
Class
G antibodies to Helycobacter pylori |
1 test |
5 891 |
| 393 |
Class
G antibodies to Chlamydia trachomatis heat shock protein (HSP60), diagnosis
of early infection |
1 test |
3 700 |
| 394 |
Class
G antibodies to major outer membrane protein (MOMP) and plasmid protein pgp3
of Chlamydia trachomatis |
1 test |
4 400 |
| 395 |
Class
G antibodies to mycoplasma (Mycoplasma hominis IgG) |
1 test |
5 100 |
| 396 |
Class
G antibodies to chlamydia (Chlamydia trachomatis IgG) |
1 test |
5 100 |
| 397 |
Class
M antibodies to chlamydia (Chlamydia trachomatis IgM) |
1 test |
5 100 |
| 398 |
Class
A antibodies to chlamydia (Chlamydia trachomatis IgA) |
1 test |
5 100 |
| 399 |
Total
antibodies class A, M, G to the Cag antigen of Helycobacter pylori |
1 test |
5 100 |
| 400 |
Total
antibodies class A, M, G to Mycobacterium tuberculosis (a-Mycobacterium
Tuberculosis) |
1 test |
5 400 |
| 401 |
Total
antibodies class A, M, G to syphilis (Treponema pallidum total) |
1 test |
5 400 |
| Specific blood proteins |
| 402 |
N-terminal
pro-brain B-type natriuretic peptide (NT-pro BNP) |
1 test |
11 300 |
| 403 |
Troponin
I (TNI), quantitation |
1 test |
12 500 |
| 404 |
Troponin
I high sensitivity (TNI), quantitation |
1 test |
14 700 |
| 405 |
Rapid
test for the qualitation of Troponin I (TNI) and myoglobin |
1 test |
3 900 |
| 406 |
Brain
natriuretic peptide (BNP) |
1 test |
34 000 |
| |
| 407 |
Neutrophil
gelatinase-associated lipocalin, NGAL |
1 test |
10 800 |
| Microbiological testings |
| Bacteriological testings |
| 408 |
Bacteriological
examination of autopsy material |
1 test |
11 000 |
| 409 |
Bacteriological
examination of biomaterial from the nose for staphylococcus |
1 test |
9 300 |
| 410 |
Bacteriological
examination of biomaterial for anaerobes |
1 test |
9 600 |
| 411 |
Bacteriological
examination of biomaterial for yersiniosis |
1 test |
9 300 |
| 412 |
Bacteriological
examination of biomaterial for meningococcus |
1 test |
11 900 |
| 413 |
Bacteriological
examination of biomaterial for microflora |
1 test |
15 300 |
| 414 |
Bacteriological
examination of biomaterial for the presence of the causative agent of
diphtheria |
1 test |
11 000 |
| 415 |
Bacteriological
examination of biomaterial for the presence of fungi with identification of
their species |
1 test |
10 700 |
| 416 |
Bacteriological
examination of stool for cholera (form 30) |
1 test |
11 000 |
| 417 |
Bacteriological
blood test for sterility using a bacteriological analyzer |
1 test |
14 200 |
| 418 |
Bacteriological
test for group B streptococcus (GBS) |
1 test |
24 600 |
| 419 |
Taking
biomaterial for microbiological research |
1 test |
2 000 |
| 420 |
Test
for intestinal dysbiosis |
1 test |
23 800 |
| 421 |
Bacteriological
examination of feces for pathogenic and opportunistic intestinal microflora
with sensitivity determination |
1 test |
8 800 |
| 422 |
Identification
of a pure culture of a microorganism using mass spectrometry |
1 test |
3 500 |
| 423 |
Bacteriological
examination of biomaterial for meningococcus PASTOREX MENINGITIS |
1 test |
37 400 |
| 424 |
Bacteriological
examination of genital secretions using the Genital SYSTEM method |
1 test |
25 500 |
| 425 |
Gene-Xpert
Determination of M. tuberculosis and rifampicin resistance |
1 test |
62 900 |
| Sanitary and bacteriological testings |
| 426 |
Bacteriological
air testing (1 room) |
1 test |
3 500 |
| 427 |
Bacteriological
examination of liquid dosage forms and material for sterility (10 samples) |
1 test |
5 600 |
| 428 |
Bacteriological
testing swabs from environmental objects for coliform bacteria (coliforms),
pathogenic intestinal flora, golden staff |
1 test |
2 500 |
| Sputum examinations |
| 429 |
Microscopic
examination of biomaterial for the presence of acid-fast bacteria (AFB) for
suspected tuberculosis |
1 test |
4 000 |
| Parasitological examination of stool |
| 430 |
Examination
of stool for helminth eggs using a fecal parasite concentrator |
1 test |
4 200 |
| 431 |
Examination
of stool for protozoa and helminth eggs |
1 test |
2 700 |
| Serological diagnosis of syphilis |
| 432 |
Microreaction |
1 test |
2 100 |
| 433 |
Wasserman
reaction (RW) |
1 test |
6 200 |
| 434 |
Syphilis,
Rapid test (Specific antibodies to Treponema pallidum, qualitative
determination) |
1 test |
5 700 |
| Molecular biological research (PCR) |
| PCR based bacterial infections diagnostics |
| 435 |
Brucella
DNA (DNA Brucella species) |
1 test |
8 500 |
| 436 |
DNA
of the causative agent of respiratory mycoplasmosis/chlamydia (Mycoplasma
pneumoniae/Chlamydophila pneumoniae DNA) |
1 test |
10 500 |
| 437 |
Mycobacterium
tuberculosis DNA (Mucobacterium tuberculosis DNA) |
1 test |
6 100 |
| 438 |
Toxoplasma
gondii DNA |
1 test |
5 900 |
| PCR based viral hepatitis diagnostics |
| 439 |
Hepatitis
C virus genotyping: 1a, 1b, 2, 3a, 4b genotypes (HCV Genotype, HCV
Genotyping/Subtyping) Genotyping/Subtyping) |
1 test |
21 400 |
| 440 |
Hepatitis
B virus DNA, qualitaion (HBV DNA Qualitative) |
1 test |
14 400 |
| 441 |
Hepatitis
B virus DNA, quantitation (HBV DNA viral load, HBV DNA Quant.) |
1 test |
20 000 |
| 442 |
Hepatitis
D virus RNA, qualitation (HDV RNA Qualitative) |
1 test |
16 100 |
| 443 |
Hepatitis
C virus RNA quantitation (HCV RNA viral load, HCV RNA Quant.) |
1 test |
22 400 |
| 444 |
Hepatitis
C virus RNA, qualitation (HCV RNA, RNA HCV Qualitative) |
1 test |
15 800 |
| PCR based viral infections diagnostics |
| 445 |
PCR
based diagnostics of the COVID-19 virus |
1 test |
7 500 |
| 446 |
DNA
cytomegalovirus (DNA Cytomegalovirus Quant), quantitation) |
1 test |
17 000 |
| 447 |
DNA
of Gardnerella and others (Florocenosis/bacterial vaginosis) quantitation |
1 test |
7 900 |
| 448 |
Human
papillomavirus DNA of high carcinogenic risk, screening (HPV DNA, high-risk
HPV DNA) |
1 test |
17 800 |
| 449 |
Varicella-Zoster
virus DNA (VZV DNA, DNA Varicella-Zoster virus, DNA VZV) |
1 test |
4 200 |
| 450 |
DNA
Rubella virus (DNA Rubella virus) |
1 test |
4 400 |
| 451 |
Human
papillomavirus DNA 16/18 types (HPV DNA 16/18, DNA НРV 16/18) |
1 test |
10 200 |
| 452 |
DNA
of herpes simplex virus types 1 and 2 (DNA HSV 1, 2) |
1 test |
10 200 |
| 453 |
Epstein-Barr
virus DNA (DNA EBV Qualitative), qualitation |
1 test |
5 100 |
| 454 |
Epstein-Barr
virus DNA (EBV DNA, DNA EBV Quant), quantitation) |
1 test |
10 200 |
| 455 |
DNA
of ARVI pathogens |
1 test |
11 000 |
| 456 |
DNA
cytomegalovirus (DNA Cytomegalovirus) |
1 test |
12 700 |
| 457 |
Detection of the
DNA of the causative agent of pertussis |
1 test |
8 840 |
| 458 |
Detection of the
DNA of the causative agent of pneumocysosis |
1 test |
8 500 |
| 459 |
— Detection of
human metapneumovirus RNA and human parainfluenza virus type 2 RNA |
1 test |
22 100 |
| PCR based urogenital infections diagnostics |
| 460 |
DNA
of ureaplasma and mycoplasma (Florocenosis/ureaplasma, mycoplasma)
(quantitation) |
1 test |
7 800 |
| 461 |
Candida
DNA (Florocenosis/Candida) (quantitation) |
1 test |
7 600 |
| 462 |
Candida
albicans DNA |
1 test |
6 200 |
| 463 |
Chlamydia
trachomatis DNA |
1 test |
6 200 |
| 464 |
Gardnerella
vaginalis DNA |
1 test |
6 200 |
| 465 |
Mycoplasma
genitalum DNA |
1 test |
6 200 |
| 466 |
Mycoplasma
hominis DNA |
1 test |
6 200 |
| 467 |
Neisseria
gonorrhoeae DNA |
1 test |
6 200 |
| 468 |
Trichomonas
vaginalis DNA |
1 test |
6 200 |
| 469 |
Ureaplasma
species DNA |
1 test |
6 200 |
| PCR based other infections diagnostics |
| 470 |
DNA
of helminthiasis pathogens (Ascaris lumbricoides, Enterobius vermicularis,
Opisthorchis felineus, Taenia solium, Diphyllobothrium latum) |
1 test |
12 800 |
| 471 |
DNA
from pathogens of protozoal infections (Lamblia Intestinalis Giardia,
Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium
parvum, Entamoeba histolytica) |
1 test |
12 800 |
| General clinical studies |
| General clinical stool examinations |
| 472 |
Examination
of feces for occult blood |
1 test |
3 700 |
| 473 |
Test
for Helicobacter pylori antigen (qualitation, rapid test) |
1 test |
7 100 |
| 474 |
Calprotectin
(qualitation, rapid test) |
1 test |
11 000 |
| 475 |
Calprotectin
(quantitation by enzyme immunoassay) |
1 test |
17 000 |
| 476 |
Coprogram |
1 test |
5 100 |
| General clinical urine tests |
| 477 |
Protein
in daily urine |
1 test |
2 800 |
| 478 |
Urinalysis
according to Nechiporenko |
1 test |
3 400 |
| 479 |
Daily
urinу analysis according to Zimnitsky |
1 test |
3 400 |
| 480 |
Microalbumin
(MAU) in a single portion of urine (semi-quantitative determination) |
1 test |
1 700 |
| 481 |
General
sputum analysis |
1 test |
3 400 |
| 482 |
General
urinalysis (UCA) |
1 test |
2 300 |
| 483 |
Rhinocytogram
(cellular composition) |
1 test |
3 700 |
| 484 |
Three-glass
urine sample |
1 test |
2 200 |
| Сlinical examinations of urethral and vaginal discharge |
| 485 |
Microscopic
examination of urethral discharge (urethral smear) |
1 test |
3 900 |
| 486 |
Microscopic
examination of prostate secretion (prostate gland) |
1 test |
3 900 |
| 487 |
Determining
the degree of purity of a gynecological smear |
1 test |
5 100 |
| 488 |
Spermogram
with determination of sperm morphology |
1 test |
14 400 |
| 489 |
MAR
test |
1 test |
12 700 |
| Сlinical examinations of other biomaterial |
| 490 |
Biomaterial
examination for the genus Demodex (Demodex) |
1 test |
3 400 |
| 491 |
Biomaterial
examination for the pathogenic fungi |
1 test |
2 800 |
| 492 |
Clinical
examination of cerebrospinal fluid (CSF, cerebrospinal fluid) |
1 test |
2 000 |
| 493 |
Clinical
examination of duodenal contents (bile) |
1 test |
4 700 |
| 494 |
Clinical
examination of serous cavities fluids and cysts (exudate, transudate) |
1 test |
2 200 |
| 495 |
Microscopic
examination of a smear stained according to Romanovsky |
1 test |
3 200 |
| 496 |
Microscopic
examination of skin scrapings for the scabies mites. |
1 test |
3 400 |
| Genomic laboratory services |
| 497 |
Molecular
genetic analysis of mutations, chimeric transcripts and copy number variants
in 52 key genes connected with canceration, pan |
1 test |
765 000 |
| 498 |
Molecular
genetic analysis of mutations, chimeric transcripts and copy number variants
in 69 key genes connected with the development of myeloid disorders |
1 test |
816 000 |
| 499 |
Molecular
genetic diagnosis of V600E mutations in the BRAF gene from tumor cells
enclosed in paraffin sections |
1 test |
49 300 |
| 500 |
Molecular
genetic diagnosis of mutations in the ALK gene from tumor cells enclosed in
paraffin sections |
1 test |
76 500 |
| 501 |
Whole
exome sequencing of human DNA to search for a presumably hereditary disease
with interpretation of the results |
1 test |
1 870 000 |
| 502 |
Mutations
in HLA CLASS II genes - DQ2, DQ8, DQA1*05 in celiac disease using real-time
PCR |
1 test |
153 000 |
| 503 |
FISH
diagnostics of bone marrow cells to identify the chimeric gene BCR/ABL
t(9;22), in CML and ALLrh+ |
1 test |
85 000 |
| 504 |
FISH
diagnosis of bladder cancer to detect aneuploidy of chromosomes 3, 7, 17 and
deletion of the 9p21 locus |
1 test |
125 800 |
| 505 |
FISH
diagnosis of numerical chromosomal pathologies 13, 18, 21, X and Y in
amniotic fluid |
1 test |
100 300 |
| 506 |
Qualitation
of the chimeric gene BCR/ABL-t(9;22) using real-time PCR |
1 test |
27 200 |
| 507 |
Quantitative
determination of the BCR/ABL-t(9;22) chimeric gene using real-time PCR |
1 test |
45 900 |
| 508 |
Molecular
genetic diagnosis using MLPA method of large deletions/duplications in the
SMN1 and SMN2 genes associated with spinal muscular atrophy |
1 test |
119 800 |
| 509 |
Minimal
residual disease |
1 test |
45 900 |
| 510 |
Mutation
in the DMD gene in Duchenne muscular dystrophy using the MLPA method |
1 test |
119 800 |
| 511 |
Standard
cytogenetic research (karyotyping) of peripheral blood cells |
1 test |
51 000 |
| 512 |
Quantitative
and qualitative molecular genetic diagnosis of the chimeric gene
BCR/ABL-t(9;22), determination of the type of BCR/ABL gene transcript in hemo |
1 test |
73 100 |
| 513 |
Molecular
genetic analysis (genotyping) of mutations in genes associated with the risk
of arterial hypertension and diabetes mellitus 2 s |
1 test |
101 500 |
| 514 |
Molecular
genetic diagnosis of V617F mutations in the JAK2 gene in myeloproliferative
diseases |
1 test |
45 900 |
| 515 |
Molecular
genetic assessing the ratios of human microorganisms (microbiome) |
1 test |
283 900 |
| 516 |
Molecular
genetic prenatal diagnosis of amniotic fluid cells for aneuploidy of
chromosomes 13, 18, 21, X, Y |
1 test |
95 200 |
| 517 |
Molecular
genetic analysis (genotyping) of mutations in genes associated with changes
in pharmacological response |
1 test |
101 500 |
| 518 |
Molecular
genetic analysis of mutations in 12 genes associated with epidermolysis
bullosa |
1 test |
297 500 |
| 519 |
Molecular
genetic analysis of sensitivity to imatinib for patients with the Ph
chromosome in CML and ALLPh+ |
1 test |
49 300 |
| 520 |
Preimplantation
molecular genetic screening of embryos for chromosomal pathologies on 24
chromosomes |
1 test |
187 000 |
| 521 |
Molecular
genetic diagnosis of polymorphism for susceptibility genes PNPLA3 and TM6SF2
in non-alcoholic steatohepatitis |
1 test |
24 100 |
| 522 |
Mutations
in the BRCA gene Oncomine Research Assay |
1 test |
542 300 |
| 523 |
Mutations,
chimeric transcripts and copy number variants in 161 genes associated with
canceration, ONCOMINE Comprehensive ASSAY panel |
1 test |
748 000 |
| 524 |
Genealogical
origin by Y chromosome |
1 test |
133 400 |
| 525 |
Mutations
in the FLT3 gene (ITD, TKD - D835F) by molecular genetic method |
1 test |
54 400 |
| 526 |
JAK2
gene mutations in exon 12 by MLPA method (fragment analysis) |
1 test |
76 500 |
| 527 |
Mutation
in the PIK3CA gene using a molecular genetic method |
1 test |
76 500 |
| 528 |
Mutations
in the CFTR gene in cystic fibrosis |
1 test |
121 500 |
| 529 |
Individual
sensitivity to warfarin |
1 test |
63 700 |
| 530 |
Microdeletions
(fragment analysis) using the MLPA method for delayed psychomotor development |
1 test |
119 800 |
| 531 |
Genotyping
in Amyotrophic Lateral Sclerosis |
1 test |
73 100 |
| 532 |
Mutations
in the KRAS gene |
1 test |
171 700 |
| 533 |
Molecular
genetic analysis for microsatellite instability (MSI) |
1 test |
193 800 |
| 534 |
Fetal
Rh factor in maternal blood |
1 test |
79 000 |
| 535 |
Mutations
in freely circulating tumor DNA |
1 test |
1 020 000 |
| 536 |
Mutations
in the NF1 gene in neurofibromatosis using the MLPA method |
1 test |
367 200 |
| 537 |
Chimeric gene
KIAA-BRAF, BRAF V600E by MLPA |
1 test |
153 000 |
| 538 |
ERBB2 (HER2)
gene amplification |
1 test |
136 000 |
| 539 |
Non-invasive
prenatal testing for the risk of aneuploidies (chromosomes 13,18,21) |
1 test |
255 000 |
| 540 |
Determination of
CD274 (PD-L1) gene amplification |
1 test |
149 600 |
| 541 |
Detection of
SMN1 and SMN2 gene mutations using PCR |
1 test |
11 050 |
| Gliomas diagnostics |
| 542 |
Detection of aberrant methylation (MGMT) |
1 test |
77 300 |
| 543 |
Detection
of mutations in the IDH1 and IDH2 genes |
1 test |
77 300 |
| 544 |
Detection
of WNT and SHH pathway activation mutations |
1 test |
106 200 |
| 545 |
Detection of mutations in the CDKN2A/2B
genes |
1 test |
77 300 |
| 546 |
Detection of mutations in the EGFR gene |
1 test |
77 300 |
| 547 |
Detection of mutations in the ATRX gene |
1 test |
77 300 |
| 548 |
Detection of mutations in the TP53 gene |
1 test |
77 300 |
| 549 |
Detection of 1p/19q co-expression |
1 test |
77 300 |
| 550 |
Detection
of H3K27 mutation |
1 test |
178 500 |
| 551 |
Detection
of mutations in the MYCN gene |
1 test |
77 300 |
| 552 |
Detection of RELA fusion mutation |
1 test |
155 500 |
| 553 |
C19MC
gene, miRNA profiling |
1 test |
60 300 |
| 554 |
Detection of mutations in the VEGF
gene
|
1 test |
71 400 |
| 555 |
“Glioma” panel (Mutation status of tumor
cells in gliomas |
1 test |
731 000 |
| 556 |
Detection of
mutations in the FGFR gene |
1 test |
102 000 |
